Back
P3 Health Partners Quote, Financials, Valuation and Earnings
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
37
PIII
P3 Health Partners
Last Price:
0.23
Seasonality Move:
-49.43%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereP3 Health Partners Price Quote
$0.23
+0.00 (+9.84%)
(Updated: November 16, 2024 at 5:33 AM ET)
P3 Health Partners Key Stats
Sell
37
P3 Health Partners (PIII)
is a Sell
Day range:
$0.20 - $0.23
52-week range:
$0.21 - $1.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.03
P/B ratio:
0.2%
Volume:
882.9K
Avg. volume:
865.6K
1-year change:
-82.56%
Market cap:
$33.9M
Revenue:
$1.3B
EPS:
$-0.67
How Much Does P3 Health Partners Make?
-
How Much Are P3 Health Partners's Sales Annually?
PIII Revenues are $1.3B -
How Much Profit Does P3 Health Partners's Make A Year?
PIII net income is -$57.8M
Is P3 Health Partners Growing As A Company?
-
What Is P3 Health Partners's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.15% -
What Is P3 Health Partners's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
P3 Health Partners Stock Price Performance
-
Did P3 Health Partners Stock Go Up Last Month?
P3 Health Partners share price went down by -33.21% last month -
Did PIII's Share Price Rise Over The Last Year?
PIII share price fell by -82.56% over the past 1 year
What Is P3 Health Partners 52-Week High & Low?
-
What Is P3 Health Partners’s 52-Week High Share Price?
P3 Health Partners has traded as high as $1.78 over the past 52 weeks -
What Is P3 Health Partners’s 52-Week Low Share Price?
P3 Health Partners has traded as low as $0.21 over the past 52 weeks
P3 Health Partners Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy P3 Health Partners?
-
How Much Debt Does P3 Health Partners Have?
Total long term debt quarterly is $134M -
How Much Cash Does P3 Health Partners Have?
Cash and short term investments quarterly total is $73.1M -
What Is P3 Health Partners’s Book Value Per Share?
Book value per share is 1.03
Is P3 Health Partners Cash Flow Positive?
-
What Is PIII Cash Flow From Operations?
Cash flow from operations (TTM) is -$53.7M -
What Is P3 Health Partners’s Cash Flow From Financing?
Cash flow from financing (TTM) is $66.6M -
What Is P3 Health Partners’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$175K
P3 Health Partners Return On Invested Capital
-
Is Management Doing A Good Job?
PIII return on invested capital is -12.43% -
What Is P3 Health Partners Return On Assets?
ROA measures how assets are converting to revenues and is -7.87% -
What Is PIII Return On Equity?
ROE is a measure of profitability and is -16.7%
P3 Health Partners Earnings Date & Stock Price
-
What Is P3 Health Partners's Stock Price Today?
A single share of PIII can be purchased today for 0.23 -
What Is P3 Health Partners’s Stock Symbol?
P3 Health Partners trades on the nasdaq under the ticker symbol: PIII -
When Is P3 Health Partners’s Next Earnings Date?
The next quarterly earnings date for P3 Health Partners is scheduled on March 28, 2025 -
When Is PIII's next ex-dividend date?
P3 Health Partners's next ex-dividend date is November 18, 2024 -
How To Buy P3 Health Partners Stock?
You can buy P3 Health Partners shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
P3 Health Partners Competitors
-
Who Are P3 Health Partners's Competitors?
Below is a list of companies who compete with P3 Health Partners or are related in some way:
P3 Health Partners Dividend Yield
-
What Is PIII Dividend Yield?
P3 Health Partners’s dividend yield currently is 0% -
What Is P3 Health Partners’s Payout Ratio?
P3 Health Partners’s payout ratio is 0% -
When Did P3 Health Partners Last Pay A Dividend?
The latest dividend pay date is November 18, 2024 -
What Is P3 Health Partners’s Dividend Per Share?
P3 Health Partners pays a dividend of $0.00 per share
P3 Health Partners Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 15.22% | 1.14% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 0.95 |
| Upside from Last Price: | 315.75% |